Teva ADR Earnings Report

Investing.com – Teva ADR (NYSE: TEVA) reported a third quarter EPS of $0.69, which is $0.03 better than the analyst estimate of $0.66. Revenue for the quarter was $4.33B, exceeding the consensus estimate of $4.14B.

Teva ADR's stock price closed at $18.77. It has risen 7.69% in the last three months and 107.63% over the past twelve months.

In the last 90 days, Teva ADR experienced 2 positive EPS revisions and 3 negative EPS revisions. You can view Teva ADR's stock price reactions to earnings here.

According to InvestingPro, Teva ADR's Financial Health score reflects great performance.

For updates on Teva ADR's recent earnings performance and financials, check out this link.

Stay informed about upcoming earnings reports by visiting Investing.com's earnings calendar.